Evidence map›Paper›PMID 33666556›Full record

ArticleJMIR research protocols2021

Extreme Prematurity and Pulmonary Outcomes Program in Saitama: Protocol for a Prospective Multicenter Cohort Study in Japan.

Fumihiko Namba, Kosuke Tanaka, Sayu Omori, Kazushige Ikeda, Ken Kawabata, Hiroaki Sato, Masakazu Honda, Tomonori Ichikawa, Yoshihiro Minosaki, Takehiro Michikawa and 2 more

Open access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 2 countries.

Fumihiko NambaDepartment of Pediatrics, Saitama Medical Center, Saitama Medical University, Saitama, Japan.ORCID https://orcid.org/0000-0001-6137-4477
Kosuke TanakaDepartment of Pediatrics, Saitama Medical Center, Saitama Medical University, Saitama, Japan.ORCID https://orcid.org/0000-0001-5436-6399
Sayu OmoriDivision of Neonatology, Department of Pediatrics, Saitama City Hospital, Saitama, Japan.ORCID https://orcid.org/0000-0002-4619-8126
Kazushige IkedaDivision of Neonatology, Department of Pediatrics, Saitama City Hospital, Saitama, Japan.ORCID https://orcid.org/0000-0002-3097-2156
Ken KawabataDivision of Neonatology, Saitama Children's Medical Center, Saitama, Japan.ORCID https://orcid.org/0000-0001-8184-1861
Hiroaki SatoDivision of Neonatology, Department of Perinatal and Neonatal Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.ORCID https://orcid.org/0000-0002-3821-670X
Masakazu HondaDivision of Neonatal Medicine, Department of Pediatrics, Saitama Medical University Hospital, Saitama, Japan.ORCID https://orcid.org/0000-0001-5678-3487
Tomonori IchikawaNeonatal Intensive Care Unit, Kawaguchi Municipal Medical Center, Saitama, Japan.ORCID https://orcid.org/0000-0001-5308-5325
Yoshihiro MinosakiNeonatal Intensive Care Unit, Kawaguchi Municipal Medical Center, Saitama, Japan.ORCID https://orcid.org/0000-0002-8526-013X
Takehiro MichikawaDepartment of Environmental and Occupational Health, School of Medicine, Toho University, Tokyo, Japan.ORCID https://orcid.org/0000-0002-2298-5133
Shuntaro OkaDepartment of Pediatrics, Saitama Medical Center, Saitama Medical University, Saitama, Japan.ORCID https://orcid.org/0000-0002-0294-0632
Kazuhiko KabeDepartment of Pediatrics, Saitama Medical Center, Saitama Medical University, Saitama, Japan.ORCID https://orcid.org/0000-0002-9378-9295
Social Insurance Saitama Chuo Hospital · JPSaitama Municipal Hospital · JPToho University · JPJichi Medical University · JPNoguchi Hospital · JPSaitama Children's Medical Center · JPSaitama Medical University Hospital · JPSynopsys (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBecause of the improvements in survival rates for preterm infants, not only the rates of bronchopulmonary dysplasia (BPD) but also those of long-term respiratory complications of premature birth are increasing, resulting in financial and health burdens in developed countries. Thus far, the risk factors of respiratory morbidities in extremely preterm infants remain unknown. Furthermore, the definition and the predictive ability of BPD for long-term respiratory outcomes are yet to be determined.

objectiveThe objective of our study, Extreme Prematurity and Pulmonary Outcomes Program in Saitama, is to develop the diagnostic criteria for BPD and to determine the prognostic factors contributing to the long-term pulmonary outcomes manifesting in extremely preterm infants.

methodsThe Extreme Prematurity and Pulmonary Outcomes Program in Saitama is an observational prospective cohort study performed by a consortium of six neonatal intensive care units (NICUs) in Saitama, Japan. The subjects included in this study are infants (from each clinical center) with gestational ages 22 to 27 weeks. The target is 400 subjects. This study aims to determine the definition of BPD and other perinatal factors that accurately predict the long-term pulmonary outcomes in survivors of extreme prematurity. Moreover, the association between BPD and postprematurity respiratory disease will be investigated using generalized linear models.

resultsThe protocol and consent forms were evaluated and approved on September 5, 2019, by the Ethics Committee of Saitama Medical Center, Saitama Medical University. Enrollment began on April 1, 2020. It is expected to end on March 31, 2023. The follow-up for 1 year corrected age is expected to continue through the middle of 2024.

conclusionsThe Extreme Prematurity and Pulmonary Outcomes Program in Saitama incorporates aspects of neonatal care in secondary- and tertiary-level NICUs to develop existing research studies on the definition of BPD, objective biomarkers, and outcome measures of respiratory morbidity in extremely preterm infants beyond NICU hospitalization, thereby leading to a novel understanding of the nature and natural history of BPD and potential mechanistic and therapeutic targets in at-risk subjects. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/22948.

Indexed as

bronchopulmonary dysplasiaprematuritypreterm infantrespiratory outcome

Identifiers

PMID33666556
PMCPMC7980118
OpenAlexW3124794804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.